Bittner, B., Locke, K. W., Maneval, D. C., Flamion, B., Connor, R. J., Kang, D. W., & Tannenbaum, R. (2022). ENHANZE® drug delivery technology: Advancing subcutaneous drug delivery using recombinant human hyaluronidase PH20. UK: Karger.
Chicago Style CitationBittner, Beate, Kenneth W. Locke, Daniel C. Maneval, Bruno Flamion, Robert J. Connor, David W. Kang, and Renee Tannenbaum. ENHANZE® Drug Delivery Technology: Advancing Subcutaneous Drug Delivery Using Recombinant Human Hyaluronidase PH20. UK: Karger, 2022.
MLA CitationBittner, Beate, et al. ENHANZE® Drug Delivery Technology: Advancing Subcutaneous Drug Delivery Using Recombinant Human Hyaluronidase PH20. UK: Karger, 2022.
Warning: These citations may not always be 100% accurate.